Cancer is a multifaceted disease influenced by genetic, environmental, and lifestyle factors. Certain groups of individuals are at significantly higher risk of developing cancer due to these factors. For high-risk populations, timely cancer screening plays a crucial role in enabling early detection and intervention, ultimately improving health outcomes.
Cancer is a multifactorial disease influenced by genetic, environmental, and lifestyle factors. With advancements in molecular biology and genetic technologies, personalized medicine is becoming a cornerstone of early cancer detection and management. Onco-D-clare, an advanced cancer risk assessment tool, integrates genetic data analysis and molecular diagnostics to provide a comprehensive understanding of individual cancer risks. This article explores the principles, applications, and potential impact of Onco-D-clare on cancer risk management.
The continuous advancement of cancer detection technology has provided more options for the formulation of precision care and personalized plans. Among them, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA), as two core liquid biopsy technologies, have attracted much attention due to their unique advantages. However, in practical applications, how to choose appropriate detection methods based on the patient’s specific situation and care goals has become a key issue. This article will explore in depth the characteristics, applicable scenarios, and application potential of CTC and ctDNA in cancer care.
As advancements in cancer treatment continue, personalized cancer care is emerging as a dominant trend. In contrast, non-personalized care, while offering certain therapeutic benefits, often lacks the in-depth analysis and tailored strategies required for optimal outcomes. RGCC leads the shift toward personalized solutions, offering precise and effective care plans tailored to individual patients. Below is a comparison of personalized versus non-personalized cancer care:
Onconomics Extract Plus is an innovative blood testing technology introduced by RGCC (The Research Genetic Cancer Center) designed to provide early cancer detection, treatment monitoring, and personalized care by analyzing metabolites and biomarkers in the blood. This test identifies characteristic substances produced by tumor cells during metabolic processes, offering real-time diagnostic information and personalized care guidance for physicians. The Onconomics Extract Plus test enables a more precise understanding of cancer progression, treatment responses, and patient care.
Oncotrace is a blood-based diagnostic technology developed by RGCC (The Research Genetic Cancer Center), designed to detect circulating tumor cells (CTCs) and related biomarkers in cancer patients’ blood. This test aims to provide real-time monitoring and assessment of cancer progression, predict the risk of recurrence, and guide personalized treatment strategies, ultimately improving patient outcomes and quality of life.
Chemotherapy sensitivity testing is an innovative technology that helps doctors choose the best chemotherapy drugs for cancer patients. By analyzing the response of tumor cells to different chemotherapy drugs, doctors can develop more precise treatment plans based on test results to maximize treatment effects and reduce unnecessary side effects. With the advancement of technology, chemotherapy sensitivity testing now covers circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), natural substances, and epigenetic analysis and other new technologies, providing a more comprehensive and personalized choice for cancer treatment. .
Lung cancer is a common and serious disease with symptoms that vary depending on the progression of the disease, and it is critical for patients and clinicians to understand these symptoms, the focus of treatment medications, and the latest approaches to individualized treatment. Here’s a look at the symptoms of lung cancer, the main medical treatments, and how to use comprehensive testing tools to optimize treatment.
胃镜检查（Gastroscopy）是消化系统疾病诊断的重要工具，特别是用于检测胃癌。胃癌在全球范围内是常见且致命的癌症之一，并且在早期阶段通常没有明显症状。因此，胃镜检查对于高风险人群来说是筛查和预防胃癌的关键。本文将介绍胃镜检查的用途、程序、何时需要检查以及其在癌症预防中的作用。
Prostate examinations are a crucial aspect of men’s health, particularly for the early detection and prevention of prostate-related conditions, such as benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer. Early detection through proper screening enables timely intervention and treatment. This article will introduce the main methods of prostate examination, the procedures involved, and their significance in maintaining men’s health.